- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Dr Reddy's Laboratories Ltd
+ Add to WatchlistDRRD:IN
2,078.30 INR 40.65 1.92%As of 07:05:55 ET on 05/17/2013.
Snapshot for Dr Reddy's Laboratories Ltd (DRRD)
| Open: | 2,126.80 | Day's Range: | 2,070.80 - 2,126.80 | Volume: | 259,539 |
|---|---|---|---|---|---|
| Previous Close: | 2,118.95 | 52wk Range: | 1,526.40 - 2,152.00 | 1-Yr Rtn: | +26.24% |
Key Statistics for DRRD
| Current P/E Ratio (ttm) | 21.0312 |
|---|---|
| Estimated P/E(03/2014) | 19.0547 |
| Relative P/E vs. SENSEX | 1.2977 |
| Earnings Per Share (INR) (ttm) | 98.8200 |
| Est. EPS (INR) (03/2014) | 109.0700 |
| Est. PEG Ratio | 1.1027 |
| Market Cap (M INR) | 352,821.28 |
| Shares Outstanding (M) | 169.76 |
| 30 Day Average Volume | 417,834 |
| Price/Book (mrq) | 4.8297 |
| Price/Sale (ttm) | 3.0346 |
| Dividend Indicated Gross Yield | 0.72% |
| Cash Dividend (INR) | 15.0000 |
| Last Dividend | |
| 5 Year Dividend Growth | 29.67% |
| Next Earnings Announcement | 07/19/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for DRRD
Company Profile & Key Executives for DRRD
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
| G V PrasadChairman/CEO | Satish ReddyVice Chairman/Mng Dir/COO |
| Saumen ChakrabortyPresident/CFO/Global Head |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
DRRD News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page